Robert F. Padera
Brigham and Women's Hospital(US)Harvard University(US)Kent Hospital(US)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Lung Cancer Treatments and Mutations, Cardiac Structural Anomalies and Repair, SARS-CoV-2 and COVID-19 Research, Cardiac Valve Diseases and Treatments
Most-Cited Works
- → BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models(2008)1,434 cited
- → Dry double-sided tape for adhesion of wet tissues and devices(2019)1,378 cited
- → Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host(2020)1,370 cited
- → Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers(2008)1,324 cited
- → LKB1 modulates lung cancer differentiation and metastasis(2007)1,060 cited
- → Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients(2003)997 cited